Latest News
April 10, 2021
Not intended for U.S. and UK Media – Plenary Session at AACR Annual Meeting 2021:
Combination of copanlisib and rituximab significantly increases progression-free survival in patients with relapsed indolent non-Hodgkin's Lymphoma
March 23, 2021
Not intended for U.S. and UK Media
Bayer receives approval for Vitrakvi™ in Japan
March 12, 2021
Elections at the Annual Stockholders' Meeting on April 27, 2021:
Bayer to further strengthen expertise and international profile of its Supervisory Board